SA’s Position on World Health Index

First-ever global study finds massive health care inequity

South Africa above the Philippines and below Namibia

People dying of preventable causes at rates higher than expected

 

SEATTLE – A first-ever global study finds massive inequity of access to and quality of health care among and within countries, and concludes people are dying from causes with well-known treatments.

South Africa has improved over the past 25 years, increasing its rating of 45 in 1990 to 52 in 2015, based on an index of 0 to 100, according to a research paper published today in the international medical journal, The Lancet.

South Africa’s current health care system ranks high in addressing common vaccine-preventable diseases, with a score of 98 in addressing diphtheria and 95 for tetanus. However, in other categories the nation had much lower scores, such as in tuberculosis and lower respiratory infections (both scores 24).

The study is the first effort to assess access and quality of services in 195 countries. Researchers used a Healthcare Access and Quality (HAQ) Index, based on death rates from 32 causes that could be avoided by timely and effective medical care, known as “amenable mortality.”

The top-ranked nation was Andorra with an overall score of 95; its lowest treatment score was for Hodgkin’s lymphoma at 70. The lowest ranked nation was Central African Republic at 29; its highest treatment score was for diphtheria at 65.

“What we have found about health care access and quality is disturbing,” said Dr. Christopher Murray, senior author of the study and Director of the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. “Having a strong economy does not guarantee good health care. Having great medical technology doesn’t either. We know this because people are not getting the care that should be expected for diseases with established treatments.”

For example, Norway and Australia each scored 90 overall, among the highest in the world. However, Norway scored 65 in its treatment for testicular cancer, and Australia scored 52 for treating non-melanoma skin cancer.

“In the majority of cases, both of these cancers can be treated effectively,” Dr. Murray said. “Shouldn’t it cause serious concern that people are dying of these causes in countries that have the resources to address them?”

Scores were based on estimates from the annual Global Burden of Diseases, Injuries, and Risk Factors study (GBD), a systematic, scientific effort to quantify the magnitude of health loss from all major diseases, injuries, and risk factors by age, sex, and population. With more than 2,300 collaborators in 133 countries, the GBD examines 300-plus diseases and injuries.

In addition, data were extracted from the most recent GBD and evaluated using a Sociodemographic Index (SDI) of rates of education, fertility, and income. SDI goes beyond the historical “developed” versus “developing” nations. Similar previous studies were limited primarily to high income countries, particularly in Western Europe.

Nations in much of sub-Saharan Africa, as well as in Asia and the Pacific, experienced the lowest rankings. Nonetheless, many countries in these regions, including China (score: 74) and Ethiopia (score: 44), have seen sizeable gains since 1990.

The paper does offer some favorable signs of improvement in health access and quality. Since 1990, several countries achieved progress that met or surpassed levels reached by other nations of similar development. These countries included Turkey, Jordan, South Korea, the Maldives, Niger, Jordan, and several Western European nations such as Switzerland, Spain, and France.

IHME plans each year to update the report, “Healthcare Access and Quality Index Based on Mortality from Causes amenable to personal Healthcare in 195 Countries and Territories, 1990 – 2015: A Novel Approach to the Global Burden of Disease 2015 Study.” It aims to use these results to better understand gaps and opportunities for improving health access throughout the world.

The Healthcare Access and Quality (HAQ) Index is a summary measure based on 32 causes, that in the presence of high-quality healthcare, should not result in death. These 32 causes were selected as part of research that Professor McKee and Dr. Ellen Nolte, both co-authors in this study, began in the early 2000s. The causes are:

  • Tuberculosis
  • Diarrhea-related diseases
  • Lower respiratory infections
  • Upper respiratory infections
  • Diphtheria
  • Whooping cough
  • Tetanus
  • Measles
  • Maternal disorders
  • Neonatal disorders
  • Colon and rectum cancer
  • Non-melanoma skin cancer
  • Breast cancer
  • Cervical cancer
  • Uterine cancer
  • Testicular cancer
  • Hodgkin lymphoma
  • Leukemia
  • Rheumatic heart disease
  • Ischemic heart disease
  • Cerebrovascular disease (stroke)
  • Hypertensive heart disease
  • Chronic respiratory diseases
  • Peptic ulcer disease
  • Appendicitis
  • Inguinal, femoral, and abdominal hernia
  • Gall bladder and biliary diseases
  • Epilepsy
  • Diabetes, urogenital, blood, and endocrine diseases
  • Chronic kidney disease
  • Congenital anomalies
  • Adverse effects of medical treatment

 

ends

Media contacts:

South Africa: Meropa Communications, tel +27115067300

Reshma Patel, reshmap@meropa.co.za or Maria Djordjevic, mariad@meropa.co.za

IHME

Dean R. Owen, +1-206-897-2858 (office); +1-206-434-5630 (cell); dean1227@uw.edu

SA’s Position on World Health Index

Leave a Reply

Your email address will not be published. Required fields are marked *